The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
Open accessAbstract
BACKGROUND: Prevention, control, and treatment of respiratory tract cancers are important steps towards achieving target 3.4 of the UN Sustainable Development Goals (SDGs)-a one-third reduction in premature mortality due to non-communicable diseases by 2030. We aimed to provide global, regional, and national estimates of the burden of tracheal, bronchus, and lung cancer and larynx cancer and their attributable risks from 1990 to 2019. METHODS: Based on the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 methodology, we evaluated the incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) of respiratory tract cancers (ie, tracheal, bronchus, and lung cancer and larynx cancer). Deaths from tracheal, bronchus, and lung cancer and larynx cancer attributable to each risk factor were estimated on the basis of risk exposure, relative risks, and the theoretical minimum risk exposure level input from 204 countries and territories, stratified by sex and Socio-demographic Index (SDI). Trends were estimated from 1990 to 2019, with an emphasis on the 2010-19 period. FINDINGS: Globally, there were 2·26 million (95% uncertainty interval 2·07 to 2·45) new cases of tracheal, bronchus, and lung cancer, and 2·04 million (1·88 to 2·19) deaths and 45·9 million (42·3 to 49·3) DALYs due to tracheal, bronchus, and lung cancer in 2019. There were 209 000 (194 000 to 225 000) new cases of larynx cancer, and 123 000 (115 000 to 133 000) deaths and 3·26 million (3·03 to 3·51) DALYs due to larynx cancer globally in 2019. From 2010 to 2019, the number of new tracheal, bronchus, and lung cancer cases increased by 23·3% (12·9 to 33·6) globally and the number of larynx cancer cases increased by 24·7% (16·0 to 34·1) globally. Global age-standardised incidence rates of tracheal, bronchus, and lung cancer decreased by 7·4% (-16·8 to 1·6) and age-standardised incidence rates of larynx cancer decreased by 3·0% (-10·5 to 5·0) in males over the past decade; however, during the same period, age-standardised incidence rates in females increased by 0·9% (-8·2 to 10·2) for tracheal, bronchus, and lung cancer and decreased by 0·5% (-8·4 to 8·1) for larynx cancer. Furthermore, although age-standardised incidence and death rates declined in both sexes combined from 2010 to 2019 at the global level for tracheal, bronchus, lung and larynx cancers, some locations had rising rates, particularly those on the lower end of the SDI range. Smoking contributed to an estimated 64·2% (61·9-66·4) of all deaths from tracheal, bronchus, and lung cancer and 63·4% (56·3-69·3) of all deaths from larynx cancer in 2019. For males and for both sexes combined, smoking was the leading specific risk factor for age-standardised deaths from tracheal, bronchus, and lung cancer per 100 000 in all SDI quintiles and GBD regions in 2019. However, among females, household air pollution from solid fuels was the leading specific risk factor in the low SDI quintile and in three GBD regions (central, eastern, and western sub-Saharan Africa) in 2019. INTERPRETATION: The numbers of incident cases and deaths from tracheal, bronchus, and lung cancer and larynx cancer increased globally during the past decade. Even more concerning, age-standardised incidence and death rates due to tracheal, bronchus, lung cancer and larynx cancer increased in some populations-namely, in the lower SDI quintiles and among females. Preventive measures such as smoking control interventions, air quality management programmes focused on major air pollution sources, and widespread access to clean energy should be prioritised in these settings. FUNDING: Bill & Melinda Gates Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Self-citationReduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Self-citationGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492
Stages of the cigarette epidemic on entering its second century
Thun, M., Peto, R., Boreham, J., & Lopez, A. D. (2012) · Tobacco Control · doi:10.1136/tobaccocontrol-2011-050294 · Cited by 583
Modeling causes of death: an integrated approach using CODEm
Foreman, K. J., Lozano, R., Lopez, A. D., & Murray, C. J. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-1 · Cited by 564
Self-citationOn the Comparable Quantification of Health Risks: Lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1999) · Epidemiology · doi:10.1097/00001648-199909000-00029 · Cited by 310
Cited by
Global burden of hematologic malignancies and evolution patterns over the past 30 years
Zhang, N., Wu, J., Wang, Q., Liang, Y., Li, X., Chen, G., Ma, L., Liu, X., & Zhou, F. (2023) · Blood Cancer Journal · doi:10.1038/s41408-023-00853-3 · Cited by 432
Kumar, P., Singh, A. B., Arora, T., Singh, S., & Singh, R. (2023) · Science of The Total Environment · doi:10.1016/j.scitotenv.2023.162163 · Cited by 380
Lung cancer in patients who have never smoked — an emerging disease
LoPiccolo, J., Gusev, A., Christiani, D. C., & Jänne, P. A. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00844-0 · Cited by 286
Metadata
- Authors
- Ebrahimi, H., Aryan, Z., Saeedi Moghaddam, S., Bisignano, C., Rezaei, S., Pishgar, F., Force, L. M., Abolhassani, H., Abu-Gharbieh, E., Advani, S. M., Ahmad, S., Alahdab, F., Alipour, V., Aljunid, S. M., Amini, S., Ancuceanu, R., Andrei, C. L., Andrei, T., Arabloo, J., Arab-Zozani, M., Asaad, M., Ausloos, M., Awedew, A. F., Baig, A. A., Bijani, A., Biondi, A., Bjørge, T., Braithwaite, D., Brauer, M., Brenner, H., Bustamante-Teixeira, M. T., Butt, Z. A., Carreras, G., Castañeda-Orjuela, C. A., Chimed-Ochir, O., Chu, D.-T., Chung, M. T., Cohen, A. J., Compton, K., Dagnew, B., Dai, X., Dandona, L., Dandona, R., Dean, F. E., Derbew Molla, M., Desta, A. A., Driscoll, T. R., Faraon, E. J. A., Faris, P. S., Filip, I., Fischer, F., Fu, W., Gallus, S., Gebregiorgis, B. G., Ghashghaee, A., Golechha, M., Gonfa, K. B., Gorini, G., Goulart, B. N. G., Guerra, M. R., Hafezi-Nejad, N., Hamidi, S., Hay, S. I., Herteliu, C., Hoang, C. L., Horita, N., Hostiuc, M., Househ, M., Iavicoli, I., Ilic, I. M., Ilic, M. D., Irvani, S. S. N., Islami, F., Kamath, A., Kaur, S., Khalilov, R., Khan, E. A., Kocarnik, J. M., Kucuk Bicer, B., Kumar, G. A., La Vecchia, C., Lan, Q., Landires, I., Lasrado, S., Lauriola, P., Leong, E., Li, B., Lim, S. S., Lopez, A. D., Majeed, A., Malekzadeh, R., Manafi, N., Menezes, R. G., Miazgowski, T., Misra, S., Mohammadian-Hafshejani, A., Mohammed, S., Mokdad, A. H., Molassiotis, A., Monasta, L., Moradzadeh, R., Morawska, L., Morgado-da-Costa, J., Morrison, S. D., Naimzada, M. D., Nazari, J., Nguyen, C. T., Nguyen, H. L. T., Nikbakhsh, R., Nuñez-Samudio, V., Olagunju, A. T., Otstavnov, N., Otstavnov, S. S., P A, M., Pana, A., Park, E.-K., Pottoo, F. H., Pourshams, A., Rabiee, M., Rabiee, N., Radfar, A., Rafiei, A., Rahman, M. A., Ram, P., Rathi, P., Rawaf, D. L., Rawaf, S., Rezaei, N., Roberts, N. L. S., Roberts, T. J., Ronfani, L., Roshandel, G., Samy, A. M., Santric-Milicevic, M. M., Sathian, B., Schneider, I. J. C., Sekerija, M., Sepanlou, S. G., Sha, F., Shaikh, M. A., Sharma, R., Sheikh, A., Sheikhbahaei, S., Siddappa Malleshappa, S. K., Singh, J. A., Sitas, F., Spurlock, E. E., Steiropoulos, P., Tabarés-Seisdedos, R., Tadesse, E. G., Takahashi, K., Traini, E., Tran, B. X., Tran, K. B., Travillian, R. S., Vacante, M., Villeneuve, P. J., Violante, F. S., Yousefi, Z., Yuce, D., Zadnik, V., Zamanian, M., Zendehdel, K., Zhang, J., Zhang, Z.-J., Farzadfar, F., Murray, C. J. L., & Naghavi, M.
- Venue
- The Lancet Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 9
- Issue
- 9
- Pages
- 1030-1049
- ISSN
- 2213-2600 (ISSN-L)
- OpenAlex
- W3193966689
- Cited by
- 237
- References
- 8
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. https://app.cochat.ai/papers/10.1016/s2213-2600(21)00164-8
- The paper
- Ebrahimi, H., Aryan, Z., Saeedi Moghaddam, S., Bisignano, C., Rezaei, S., Pishgar, F., Force, L. M., Abolhassani, H., Abu-Gharbieh, E., Advani, S. M., Ahmad, S., Alahdab, F., Alipour, V., Aljunid, S. M., Amini, S., Ancuceanu, R., Andrei, C. L., Andrei, T., Arabloo, J., . . . Naghavi, M. (2021). Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(21)00164-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.